SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-466765
Filing Date
2013-12-09
Accepted
2013-12-09 16:05:59
Documents
3
Period of Report
2013-12-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d638236d8k.htm 8-K 19980
2 EX-1.1 d638236dex11.htm EX-1.1 168914
3 EX-99.1 d638236dex991.htm EX-99.1 8730
  Complete submission text file 0001193125-13-466765.txt   198780
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35347 | Film No.: 131265694
SIC: 2834 Pharmaceutical Preparations